Abstract:Background: Aromatic compounds derived from tyrosine are important and diverse chemicals that have industrial and commercial applications. Although these aromatic compounds can be obtained by extraction from natural producers, their growth is slow, and their content is low. To overcome these problems, many of them have been chemically synthesized from petroleum-based feedstocks. However, because of the environmental burden and depleting availability of feedstock, microbial cell factories are attracting much attention as sustainable and environmentally friendly processes. Results: To facilitate development of microbial cell factories for producing tyrosine derivatives, we developed simple and convenient tyrosine-producing Escherichia coli platforms with a bacterial phenylalanine hydroxylase, which converted phenylalanine to tyrosine with tetrahydromonapterin as a cofactor, using a synthetic biology approach. By introducing a tetrahydrobiopterin-regeneration system, the tyrosine titer of the plasmid-based engineered strain was 4.63 g/L in a medium supplemented with 5.00 g/L phenylalanine with a test tube. The strains were successfully used to produce industrially attractive compounds, such as tyrosol with a yield of 1.58 g/L by installing a tyrosol-producing module consisting of genes encoding tyrosine decarboxylase and tyramine oxidase on a plasmid. Gene integration into E. coli chromosomes has an advantage over the use of plasmids because it increases genetic stability without antibiotic feeding to the culture media and enables more flexible pathway engineering by accepting more plasmids with artificial pathway genes. Therefore, we constructed a plasmid-free tyrosine-producing platform by integrating five modules, comprising genes encoding the phenylalanine hydroxylase and tetrahydrobiopterin-regeneration system, into the chromosome. The platform strain could produce 1.04 g/L of 3,4-dihydroxyphenylalanine, a drug medicine, by installing a gene encoding tyrosine hydroxylase and the tetrahydrobiopterin-regeneration system on a plasmid. Moreover, by installing the tyrosol-producing module, tyrosol was produced with a yield of 1.28 g/L. Conclusions: We developed novel E. coli platforms for producing tyrosine from phenylalanine at multi-gram-per-liter levels in test-tube cultivation. The platforms allowed development and evaluation of microbial cell factories installing various designed tyrosine-derivative biosynthetic pathways at multi-grams-per-liter levels in test tubes.

Yeast: A platform for the production of L‐tyrosine derivatives

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

L-tyrosine metabolic pathway in microorganisms and its application in the biosynthesis of plant-derived natural products

[Recent advances in metabolic engineering of microorganisms for production of tyrosol and its derivatives]

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Advanced Strategies for Production of Natural Products in Yeast

Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites

Engineered Escherichia coli platforms for tyrosine-derivative production from phenylalanine using phenylalanine hydroxylase and tetrahydrobiopterin-regeneration system

Multi‐modular engineering of Saccharomyces cerevisiae for high‐titre production of tyrosol and salidroside

Metabolic Engineering of Yeast for the Production of 3-Hydroxypropionic Acid

Biotechnological Production of Astaxanthin Through Metabolic Engineering of Yeasts

Advances in Flavonoid and Derivative Biosynthesis: Systematic Strategies for the Construction of Yeast Cell Factories

Recent Advances on Biological Synthesis of Lycopene by Using Industrial Yeast

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Rewiring central carbon metabolism for tyrosol and salidroside production in Saccharomyces cerevisiae

Heterologous biosynthesis of lutein in S. cerevisiae enabled by temporospatial pathway control

Advances in metabolic engineering for enhanced acetyl-CoA availability in yeast

Efficient synthesis of tyrosol from L-tyrosine via heterologous Ehrlich pathway in Escherichia coli

Recent Advances in Multiple Strategies for the Synthesis of Terpenes by Engineered Yeast

Engineering the L-tryptophan metabolism for efficient de novo biosynthesis of tryptophol in Saccharomyces cerevisiae

[Advances in synthesis of succinic acid using yeast cell factories]